Parkinson's disease GWAS-linked Park16 variant is associated with a lower risk of cognitive impairment: a 4-year observational study.
Bin XiaoXiao DengEbonne Yu-Lin NgYew-Long LoZheyu XuKay-Yaw TayWing-Lok AuAdeline NgLouis C S TanEng-King Tan
Published in: European journal of neurology (2023)
PD Park16 rs6679073 carriers had significantly lower frequency of MCI in a 4-year follow-up study, suggesting that the variant may have potential neuroprotective effect on cognitive functions.